Melbourne, Fla. – June 30, 2023 – The Preeclampsia Foundation is seeking Letters of Intent for the Peter Joseph Pappas Research Grants funding program, designed to accelerate preeclampsia research. The ultimate goal of this grant program is to drive research that will eliminate the delivery of pre-term babies as an intervention for severe preeclampsia, HELLP syndrome, and related hypertensive disorders of pregnancy. Named for the infant son of preeclampsia survivor Lauren Pappas and her husband Clement, the program seeks to award multiple two-year grants in 2024 totaling up to $200,000.
Eligible applicants should focus on the current research gaps identified through a 2020 preeclampsia workshop jointly sponsored by the Preeclampsia Foundation and the Society for Maternal Fetal Medicine. Examples of such proposals include but are not limited to understanding pathophysiological pathways and subtypes of preeclampsia, mechanisms for improved diagnosis or prediction, therapeutic interventions to halt, reverse, or prevent the placental and organ dysfunction associated with the condition, and supporting preconception and inter-conception health to improve perinatal outcomes. In addition to meeting the fund’s research criteria, preference will be given to proposals that use or build upon data available through the Preeclampsia Registry™ (self-reported, whole exome sequenced, and clinical data), or that will produce data or biological materials that can be added to the Registry. All criteria are outlined in the application instructions, available at www.preeclampsia.org/research-funding.
The grant is named after the son of Lauren and Clement Pappas, who was delivered at 29-weeks due to severe preeclampsia and HELLP syndrome. The program has funded almost a dozen studies, including innovative research into potential therapeutics, genetic markers, and the role of placental functioning in preeclampsia’s development.
“We lost our son Peter due to preeclampsia following a 29-week delivery,” explained Lauren Pappas. “Since then we have dedicated our lives to helping others avoid the same outcome by establishing the Peter Joseph Pappas Fund.”
“Thanks to generous contributions from family and friends, and our partnership with the Preeclampsia Foundation, we are making strides to reach our ultimate goal of eliminating pre-term births due to preeclampsia by 2050,” added Clement Pappas.
The Peter Joseph Pappas Research Grants program adds to the Preeclampsia Foundation’s portfolio of research programs including the Vision Grant program for young investigators, and the Preeclampsia Registry, a dynamic database of research participants including preeclampsia and HELLP syndrome survivors, family members, and controls (unaffected individuals).
About the Preeclampsia Foundation
The Preeclampsia Foundation is a U.S.-based 501(c)(3) non-profit organization established in 2000 to improve the outcomes of hypertensive disorders of pregnancy by educating, supporting, and engaging the community, improving healthcare practices, and finding a cure. We envision a world where preeclampsia and related hypertensive disorders of pregnancy no longer threaten the lives of mothers and babies. For more information, visit www.preeclampsia.org.
About the Peter Joseph Pappas Research Grant Program
Clement and Lauren Pappas of Philadelphia, PA, lost their firstborn child, Peter Joseph, after HELLP syndrome necessitated his early delivery. Their son, born at 29 weeks’ gestation, spent a week in the neonatal intensive care unit before dying from a central line infection. The Pappas family, along with friends and family, have established this special fund with the Preeclampsia Foundation to advance research, with the overarching goal of eliminating pre-term births due to preeclampsia by 2050.
Your story is needed to improve outcomes for moms like you. Add your voice to critical preeclampsia research to ensure that every story is heard.
The Preeclampsia Foundation's published research results.
Frequently asked questions about the Preeclampsia Registry, a patient-driven registry and biobank.
The Preeclampsia Foundation offers research funding, study recruitment, and other patient engagement services to researchers.
We provide research grant funding to advance progress towards detection, prevention, or treatment of preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy.
The Preeclampsia Foundation announced today the recipient of its 2024 Peter Joseph Pappas Research Grants at the Society for Maternal Fetal Medicine 44th Annual Pregnancy Meeting. Based on the recomme...
Preeclampsia Foundation announced today at the Society for Maternal-Fetal Medicine’s (SMFM) 44th Annual Meeting – The Pregnancy Meeting™ – that applications are now being accep...
Preeclampsia Foundation Canada has announced that Kylie Belchamber, PhD of University of Birmingham, and Serena Gundy, MD, FRCP of McMaster University, are their 2023 Vision Grant research award recip...
Amit Zeisel, PhD and Ido Solt, MD and their research team at the Technion – Israel Institute of Technology and Rambam Hospital, together with Prof. Simcha Yagel, MD of Hadassa Hospital, have pub...
Comparative effectiveness of prophylactic strategies for preeclampsia: a network meta-analysis of randomized controlled trials Finding strategies for preventing preeclampsia is a top priority in...